- Home
- TECH vs KRUS Comparison
TECH vs KRUS Comparison
Compare TECH & KRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- KRUS
- Stock Information
- Founded
- TECH 1976
- KRUS 2008
- Country
- TECH United States
- KRUS United States
- Employees
- TECH N/A
- KRUS N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- KRUS Restaurants
- Sector
- TECH Health Care
- KRUS Consumer Discretionary
- Exchange
- TECH Nasdaq
- KRUS Nasdaq
- Market Cap
- TECH 8.0B
- KRUS N/A
- IPO Year
- TECH 1989
- KRUS 2019
- Fundamental
- Price
- TECH $48.10
- KRUS $58.50
- Analyst Decision
- TECH Buy
- KRUS Buy
- Analyst Count
- TECH 9
- KRUS 9
- Target Price
- TECH $81.25
- KRUS $74.67
- AVG Volume (30 Days)
- TECH 2.2M
- KRUS 414.4K
- Earning Date
- TECH 05-07-2025
- KRUS 04-08-2025
- Dividend Yield
- TECH 0.63%
- KRUS N/A
- EPS Growth
- TECH N/A
- KRUS N/A
- EPS
- TECH 0.98
- KRUS N/A
- Revenue
- TECH $1,196,016,000.00
- KRUS $258,444,000.00
- Revenue This Year
- TECH $8.19
- KRUS $19.94
- Revenue Next Year
- TECH $8.85
- KRUS $21.13
- P/E Ratio
- TECH $49.09
- KRUS N/A
- Revenue Growth
- TECH 4.46
- KRUS 21.37
- 52 Week Low
- TECH $46.44
- KRUS $40.03
- 52 Week High
- TECH $85.57
- KRUS $121.99
- Technical
- Relative Strength Index (RSI)
- TECH 33.97
- KRUS 55.95
- Support Level
- TECH $46.44
- KRUS $45.71
- Resistance Level
- TECH $53.00
- KRUS $57.84
- Average True Range (ATR)
- TECH 3.30
- KRUS 5.29
- MACD
- TECH -0.27
- KRUS 1.59
- Stochastic Oscillator
- TECH 13.00
- KRUS 97.72
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.